Dr. Raghuram Selvaraju
H.C. Wainwright
John D. Vandermosten
Zacks Investment Research.

Protalix BioTherapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Protalix BioTherapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Protalix BioTherapeutics or its management. Protalix BioTherapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.